Press-release for stocks related to drug

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Drug crawled time : 14:30

save search

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

|

Health Technology

| -1.53% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -1.85% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

|

Health Technology

| -3.74% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -2.33% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

|

Health Technology

| 1.82% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -6.94% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

|

Health Technology

| -11.18% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -3.66% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
JAGX | $0.158 -10.79% -12.09% 30M

|

Health Technology

| 91.16% | O: 6.09% H: 7.88% C: 0.68%
fda drug diarrhea health designation application crofelemer submission

Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
Published: 2024-02-07 (Crawled : 14:30) - globenewswire.com
IMMX | $2.21 0.0% 64K

|

| -22.61% | O: -2.83% H: 11.64% C: 10.18%
nxc-201 drug biopharma designation

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
VNDA | $5.11 2.82% 2.74% 2.4M

|

Health Technology

| 40.0% | O: 1.37% H: 1.35% C: -2.7%
vtr-297 fda drug candidate approval treatment pharmaceuticals antifungal

FDA Decisions: Theratechnologies Must Address Several Questions in CRL for Lipodystrophy Drug
Published: 2024-01-25 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

|

Health Technology

| -6.69% | O: 0.73% H: 0.3% C: -0.39%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -7.35% | O: -0.35% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

|

Health Technology

| -3.26% | O: 0.47% H: 1.04% C: 0.93%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -8.39% | O: -1.27% H: 0.0% C: 0.0%
fda drug lipodystrophy

FDA Decisions: J&J's Bladder Cancer Drug Wins Full Approval
Published: 2024-01-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -8.68% | O: 1.71% H: 0.0% C: -0.15%
PRGO | News | $30.8 2.87% -1.14% 1.2M

|

Health Technology

| -6.92% | O: 0.36% H: 2.11% C: 1.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -8.13% | O: 0.6% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

|

Health Technology

| -5.84% | O: 0.88% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -9.64% | O: -0.21% H: 0.0% C: 0.0%
fda drug approval bladder cancer

FDA Decisions: CMC Issues Trip Up Satsuma in Nasal Migraine Drug Bid
Published: 2024-01-19 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -9.9% | O: -0.5% H: 0.0% C: -0.83%
PRGO | News | $30.8 2.87% -1.14% 1.2M

|

Health Technology

| -6.04% | O: 0.09% H: 1.01% C: 0.85%
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -7.52% | O: 0.67% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

|

Health Technology

| -6.06% | O: -0.24% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -10.76% | O: -1.23% H: 0.0% C: 0.0%
fda drug migraine

Pfizer, Sanofi, Takeda Look to Hike Drug Prices This Month: Reuters
Published: 2024-01-02 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -6.94% | O: -0.02% H: 0.41% C: 0.41%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -6.66% | O: -0.45% H: 0.0% C: 0.0%
drug

AbelZeta Presents Data from Two Clinical Studies Relating to its Immuno-Oncology Drug Development at the 65th ASH Annual Meeting
Published: 2023-12-12 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

|

Health Technology

| -4.39% | O: 0.1% H: 0.0% C: 0.0%
drug meeting

GigaGen Receives FDA Clearance of IND to Begin Phase 1 Trial of Oncology Drug Candidate, GIGA-564, in Solid Tumors
Published: 2023-12-12 (Crawled : 14:30) - biospace.com/
GRFS | News | $6.29 -3.82% -3.97% 1.2M

|

Health Technology

| -38.31% | O: 0.88% H: 0.49% C: -1.27%
giga-564 fda drug tumors clearance trial

Scilex Holding Company announces that ZTlido® (lidocaine topical system) will be added as a preferred agent to the Medicaid Preferred Drug List (PDL) in two new states: one Midwestern and one Southern State
Published: 2023-12-06 (Crawled : 14:30) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M

|

| -23.73% | O: 0.85% H: 1.68% C: -4.2%
ztlido drug company state one

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry DiseasePatient enrollment expected to begin in first half of 2024
Published: 2023-11-29 (Crawled : 14:30) - biospace.com/
QURE | $4.68 -0.64% -0.64% 550K

|

Health Technology

| -33.09% | O: 0.0% H: 4.58% C: -2.58%
amt-191 fda drug expected clearance application therapy

Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis
Published: 2023-11-27 (Crawled : 14:30) - biospace.com/
ARCT 4 | $25.995 -1.23% -1.25% 630K

|

Health Technology

| 8.66% | O: 2.89% H: 6.75% C: 4.88%
arct-032 fda drug treatment fibrosis designation therapeutics

Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
Published: 2023-11-16 (Crawled : 14:30) - biospace.com/
ODYY | $0.0337 354.55% 500

|

| -61.04% | O: 0.39% H: 3.49% C: 3.49%
drug health treatment application

Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001
Published: 2023-11-13 (Crawled : 14:30) - biospace.com/
ALZN | $0.6894 -0.23% -0.23% 28K

|

Professional, Scientific, and T...

| -53.42% | O: 0.0% H: 0.0% C: -6.85%
al001 drug candidate lithium application trial

GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
GRFS | News | $6.29 -3.82% -3.97% 1.2M

|

Health Technology

| -32.55% | O: -0.54% H: 1.19% C: -1.08%
giga-564 drug trial

Hepatitis C Disease Market: Clinical Trial, Drug Development, Clinical Viewpoints, and Drug Insights| Disease Landscape Insights
Published: 2023-10-12 (Crawled : 14:30) - prnewswire.com
ALPMY | $9.47 -1.11% 520K

|

| -30.04% | O: -2.72% H: 2.65% C: 2.12%
hepatitis drug disease

Brain Cancer Market: Drug Insights, Epidemiology Study, Clinical Trial Assessment, Pharma Consulting, and Regulatory Consulting | Disease Landscape Insights
Published: 2023-10-12 (Crawled : 14:30) - prnewswire.com
BRKR | $77.725 -1.06% -1.07% 1.3M

|

Health Technology

| 21.52% | O: -0.69% H: 0.91% C: -2.88%
pharma drug disease cancer trial

Cracking Down on Drug Prices: A Prescription for Positive Change
Published: 2023-10-10 (Crawled : 14:30) - nanthealth.com
NH | $1.35 -46.64% -1.48% 0

|

Technology Services

| Email alert Add to watchlist
NHIQ | $0.341 16.76% 110

|

| Email alert Add to watchlist
drug change positive

← Previous
1
2
3
Next →

Gainers vs Losers

67%

33%

Top 10 Gainers

GBR | $1.42 31.48% 11.27% 990K

|

Energy Minerals

KUKE | $2.88 2.49% 7.64% 360K

|

CXM 4 | $11.34 -0.44% 4.27% 1.7M

|

PVL 4 | $1.47 -0.68% 4.08% 77K

|

Energy Minerals

RNR 4 | $224.74 0.85% 3.52% 310K

|

KNSL 4 | $451.81 -0.02% 0.49% 140K

|

SENS | $0.3992 -4.04% 0.45% 2M

|

Electronic Technology

BSBR | $5.25 2.54% 0.38% 430K

|

DV | News | $29.43 -2.36% 0.24% 1.9M

|

JOE 4 | $54.88 1.22% 0.22% 210K

|

Your saved searches

Save your searches and get alerts when important news are released.